Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The British Heart Foundation has awarded a total of £7.6 million to research programmes at the world-leading Burdon Sanderson Cardiac Science Centre in the Department of Physiology, Anatomy and Genetics

Awardees : Left to right Dr Sarah De Val (BHF Senior Fellow), Dr Duncan Sparrow (BHF Senior Fellow), Associate Professor Pawel Swietach (BHF Programme Director), BHF Professor Paul Riley, Director of Regenerative Medicine Centre, Professor Manuela Zaccolo (BHF Programme Director & Director of Cardiac Centre), Dr Lisa Heather (BHF Intermediate Fellow),  Dr Samira Lakhal-Littleton (BHF Intermediate Fellow) & Professor David Paterson (BHF Programme Director & Head of Department).  

The BHF investment highlights the excellent quality of research, at the forefront of cardiac science today, which is carried out at the Burdon Sanderson Cardiac Science Centre. Embedded in the Oxford Cardiovascular Science network, we are grateful to the BHF Centre for Research Excellence, led by Professor Hugh Watkins, for start-up funding which enabled some of our awards.

Professor David Paterson, Head of the Department of Physiology, Anatomy and Genetics, commented: ‘Cardiac science is one of the main research themes in the Department, and this current funding is testament to the quality of the work undertaken by the 90 scientists in the Burdon Sanderson Cardiac Science Centre’.

Read more (Department of Physiology, Anatomy, and Genetics website)

British Heart Foundation 

British Heart Foundation.jpg

Similar stories

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.

Anti-cancer drug derived from fungus shows promise in clinical trials

A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.

Professor Trish Greenhalgh Highly Commended in the O²RB Excellence in Impact Awards 2021

Congratulations to Professor Trish Greenhalgh (Nuffield Department of Primary Care Health Sciences) who has been Highly Commended in the O²RB Excellence in Impact Awards 2021.

No benefit of convalescent plasma for critically ill COVID-19 patients

A large study of over 2000 COVID-19 patients has found that giving critically ill patients blood plasma from recovered COVID-19 patients did not significantly reduce deaths, or the need for intensive care support such as being put on a ventilator machine.